{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:22:47Z","timestamp":1790479367006,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2015XSZ9A2"],"award-info":[{"award-number":["2015XSZ9A2"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12035-019-01712-8","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T11:02:34Z","timestamp":1564570954000},"page":"408-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG\/Rij Rats"],"prefix":"10.1007","volume":"57","author":[{"given":"Rita","family":"Citraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"De Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Gallo Cantafio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Mattace Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Calignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tallarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8123","authenticated-orcid":false,"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"1712_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.phrs.2016.03.022","volume":"107","author":"M Mulaf","year":"2016","unstructured":"Mulaf M (2016) The pharmacological management of psychiatric comorbidities in patients with epilepsy. Pharmacol Res 107:147\u2013153. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2016.03.022","journal-title":"Pharmacol Res"},{"key":"1712_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/epi.13769","volume":"58","author":"AJ Scott","year":"2017","unstructured":"Scott AJ, Sharpe L, Hunt C, Gandy M (2017) Anxiety and depressive disorders in people with epilepsy: a meta-analysis. Epilepsia 58:973\u2013982. \nhttps:\/\/doi.org\/10.1111\/epi.13769","journal-title":"Epilepsia"},{"key":"1712_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1528-1167.2006.00685.x","volume":"47","author":"CM Cornaggia","year":"2006","unstructured":"Cornaggia CM, Beghi M, Provenzi M, Beghi E (2006) Correlation between cognition and behavior in epilepsy. Epilepsia 47:34\u201339. \nhttps:\/\/doi.org\/10.1111\/j.1528-1167.2006.00685.x","journal-title":"Epilepsia"},{"key":"1712_CR4","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0140-6736(12)61455-X","volume":"380","author":"JJ Lin","year":"2012","unstructured":"Lin JJ, Mula M, Hermann BP (2012) Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet 380:1180\u20131192. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(12)61455-X","journal-title":"Lancet"},{"key":"1712_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/epi.12298","volume":"54","author":"AR Brooks-Kayal","year":"2013","unstructured":"Brooks-Kayal AR, Bath KG, Berg AT, Galanopoulou AS, Holmes GL, Jensen FE, Kanner AM, O\u2019Brien TJ et al (2013) Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia 54:44\u201360. \nhttps:\/\/doi.org\/10.1111\/epi.12298","journal-title":"Epilepsia"},{"key":"1712_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.yebeh.2009.02.036","volume":"14","author":"MP Jacobs","year":"2009","unstructured":"Jacobs MP, Leblanc GG, Brooks-Kayal A, Jensen FE, Lowenstein DH, Noebels JL, Spencer DD, Swann JW (2009) Curing epilepsy: progress and future directions. Epilepsy Behav 14:438\u2013445. \nhttps:\/\/doi.org\/10.1016\/j.yebeh.2009.02.036","journal-title":"Epilepsy Behav"},{"key":"1712_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neulet.2017.01.012","volume":"667","author":"K Kobow","year":"2018","unstructured":"Kobow K, Bl\u00fcmcke I (2018) Epigenetics in epilepsy. Neurosci Lett 667:40\u201346. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2017.01.012","journal-title":"Neurosci Lett"},{"key":"1712_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.nbd.2010.02.005","volume":"15","author":"B Karalambev","year":"1962","unstructured":"Karalambev B (1962) A rare case of a foreign body of the fornix. Khirurgiia (Sofiia) 15:653\u2013654. \nhttps:\/\/doi.org\/10.1016\/j.nbd.2010.02.005","journal-title":"Khirurgiia (Sofiia)"},{"key":"1712_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.1186088","volume":"328","author":"S Peleg","year":"2010","unstructured":"Peleg S, Sananbenesi F, Zovoilis A et al (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science (80-) 328:753\u2013756. \nhttps:\/\/doi.org\/10.1126\/science.1186088","journal-title":"Science (80-)"},{"key":"1712_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.03.002","volume":"177","author":"I Younus","year":"2017","unstructured":"Younus I, Reddy DS (2017) Epigenetic interventions for epileptogenesis: a new frontier for curing epilepsy. Pharmacol Ther 177:108\u2013122. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2017.03.002","journal-title":"Pharmacol Ther"},{"key":"1712_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","volume":"76","author":"MD Shahbazian","year":"2007","unstructured":"Shahbazian MD, Grunstein M (2007) Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76:75\u2013100. \nhttps:\/\/doi.org\/10.1146\/annurev.biochem.76.052705.162114","journal-title":"Annu Rev Biochem"},{"key":"1712_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJM de Ruijter","year":"2003","unstructured":"de Ruijter AJM, van Gennip AH, Caron HN et al (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370:737\u2013749. \nhttps:\/\/doi.org\/10.1042\/bj20021321","journal-title":"Biochem J"},{"key":"1712_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pnpbp.2016.09.002","volume":"72","author":"X Qiu","year":"2017","unstructured":"Qiu X, Xiao X, Li N, Li Y (2017) Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases. Prog Neuro-Psychopharmacol Biol Psychiatry 72:60\u201372. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2016.09.002","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1712_CR14","doi-asserted-by":"publisher","first-page":"re12","DOI":"10.1126\/scisignal.aaa0069","volume":"7","author":"J Penney","year":"2014","unstructured":"Penney J, Tsai L-H (2014) Histone deacetylases in memory and cognition. Sci Signal 7:re12. \nhttps:\/\/doi.org\/10.1126\/scisignal.aaa0069","journal-title":"Sci Signal"},{"key":"1712_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2015.00058","volume":"9","author":"J Landgrave-G\u00f3mez","year":"2015","unstructured":"Landgrave-G\u00f3mez J, Mercado-G\u00f3mez O, Guevara-Guzm\u00e1n R (2015) Epigenetic mechanisms in neurological and neurodegenerative diseases. Front Cell Neurosci 9:58. \nhttps:\/\/doi.org\/10.3389\/fncel.2015.00058","journal-title":"Front Cell Neurosci"},{"key":"1712_CR16","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1242\/jcs.00804","volume":"116","author":"C Crosio","year":"2003","unstructured":"Crosio C (2003) Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J Cell Sci 116:4905\u20134914. \nhttps:\/\/doi.org\/10.1242\/jcs.00804","journal-title":"J Cell Sci"},{"key":"1712_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1460-9568.2006.04641.x","volume":"21","author":"H Taniura","year":"2006","unstructured":"Taniura H, Sng JCG, Yoneda Y (2006) Histone modifications in status epilepticus induced by kainate. Histol Histopathol 21:785\u2013791. \nhttps:\/\/doi.org\/10.1111\/j.1460-9568.2006.04641.x","journal-title":"Histol Histopathol"},{"key":"1712_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077710","volume":"8","author":"T Mori","year":"2013","unstructured":"Mori T, Wakabayashi T, Ogawa H, Hirahara Y, Koike T, Yamada H (2013) Increased histone H3 phosphorylation in neurons in specific brain structures after induction of status epilepticus in mice. PLoS One 8:e77710. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0077710","journal-title":"PLoS One"},{"key":"1712_CR19","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1523\/JNEUROSCI.22-19-08422.2002","volume":"22","author":"Y Huang","year":"2002","unstructured":"Huang Y, Doherty JJ, Dingledine R (2002) Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J Neurosci 22:8422\u20138428 22\/19\/8422","journal-title":"J Neurosci"},{"key":"1712_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nn1659","volume":"9","author":"NM Tsankova","year":"2006","unstructured":"Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519\u2013525. \nhttps:\/\/doi.org\/10.1038\/nn1659","journal-title":"Nat Neurosci"},{"key":"1712_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"DM Chuang","year":"2009","unstructured":"Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32:591\u2013601. \nhttps:\/\/doi.org\/10.1016\/j.tins.2009.06.002","journal-title":"Trends Neurosci"},{"key":"1712_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","volume":"8","author":"T Abel","year":"2008","unstructured":"Abel T, Zukin RS (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8:57\u201364. \nhttps:\/\/doi.org\/10.1016\/j.coph.2007.12.002","journal-title":"Curr Opin Pharmacol"},{"key":"1712_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd2681","volume":"7","author":"AG Kazantsev","year":"2008","unstructured":"Kazantsev AG, Thompson LM (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7:854\u2013868. \nhttps:\/\/doi.org\/10.1038\/nrd2681","journal-title":"Nat Rev Drug Discov"},{"key":"1712_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/13811110903479029","volume":"14","author":"SS O\u2019Connor","year":"2010","unstructured":"O\u2019Connor SS, Jobes DA, Lineberry TW, Michael Bostwick J (2010) An investigation of emotional upset in suicide ideation. Arch Suicide Res 14:35\u201343. \nhttps:\/\/doi.org\/10.1080\/13811110903479029","journal-title":"Arch Suicide Res"},{"key":"1712_CR25","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P et al (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969\u20136978. \nhttps:\/\/doi.org\/10.1093\/emboj\/20.24.6969","journal-title":"EMBO J"},{"key":"1712_CR26","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734\u201336741. \nhttps:\/\/doi.org\/10.1074\/jbc.M101287200","journal-title":"J Biol Chem"},{"key":"1712_CR27","doi-asserted-by":"publisher","first-page":"jpet.117.244939","DOI":"10.1124\/jpet.117.244939","volume":"364","author":"SD Reddy","year":"2017","unstructured":"Reddy SD, Clossen BC, Reddy DS (2017) Epigenetic histone deacetylation inhibition prevents the development and persistence of temporal lobe epilepsy. J Pharmacol Exp Ther 364:jpet.117.244939. \nhttps:\/\/doi.org\/10.1124\/jpet.117.244939","journal-title":"J Pharmacol Exp Ther"},{"key":"1712_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.neubiorev.2016.09.017","volume":"71","author":"E Russo","year":"2016","unstructured":"Russo E, Citraro R, Constanti A, Leo A, L\u00fcttjohann A, van Luijtelaar G, de Sarro G (2016) Upholding WAG\/Rij rats as a model of absence epileptogenesis: Hidden mechanisms and a new theory on seizure development. Neurosci Biobehav Rev 71:388\u2013408. \nhttps:\/\/doi.org\/10.1016\/j.neubiorev.2016.09.017","journal-title":"Neurosci Biobehav Rev"},{"key":"1712_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jneumeth.2018.05.020","volume":"310","author":"E Russo","year":"2018","unstructured":"Russo E, Citraro R (2018) Pharmacology of epileptogenesis and related comorbidities in the WAG\/Rij rat model of genetic absence epilepsy. J Neurosci Methods 310:54\u201362. \nhttps:\/\/doi.org\/10.1016\/j.jneumeth.2018.05.020","journal-title":"J Neurosci Methods"},{"key":"1712_CR30","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.pnpbp.2010.11.010","volume":"35","author":"K Sarkisova","year":"2011","unstructured":"Sarkisova K, van Luijtelaar G (2011) The WAG\/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35:854\u2013876. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2010.11.010","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1712_CR31","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s13311-017-0550-y","volume":"14","author":"A Leo","year":"2017","unstructured":"Leo A, Citraro R, Amodio N, de Sarro C, Gallo Cantafio ME, Constanti A, de Sarro G, Russo E (2017) Fingolimod exerts only temporary antiepileptogenic effects but longer-lasting positive effects on behavior in the WAG\/Rij rat absence epilepsy model. Neurotherapeutics 14:1134\u20131147. \nhttps:\/\/doi.org\/10.1007\/s13311-017-0550-y","journal-title":"Neurotherapeutics"},{"key":"1712_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/epi.13629","volume":"58","author":"R Citraro","year":"2017","unstructured":"Citraro R, Leo A, Franco V, Marchiselli R, Perucca E, de Sarro G, Russo E (2017) Perampanel effects in the WAG\/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior. Epilepsia 58:231\u2013238. \nhttps:\/\/doi.org\/10.1111\/epi.13629","journal-title":"Epilepsia"},{"key":"1712_CR33","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1523\/JNEUROSCI.0110-07.2007","volume":"27","author":"S Jessberger","year":"2007","unstructured":"Jessberger S, Nakashima K, Clemenson GD, Mejia E, Mathews E, Ure K, Ogawa S, Sinton CM et al (2007) Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J Neurosci 27:5967\u20135975. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.0110-07.2007","journal-title":"J Neurosci"},{"key":"1712_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.euroneuro.2007.11.004","volume":"18","author":"SI Deutsch","year":"2008","unstructured":"Deutsch SI, Rosse RB, Long KD, Gaskins BL, Burket JA, Mastropaolo J (2008) Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801\u2019s pharmacologic action. Eur Neuropsychopharmacol 18:565\u2013568. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2007.11.004","journal-title":"Eur Neuropsychopharmacol"},{"key":"1712_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bbr.2011.07.030","volume":"225","author":"E Russo","year":"2011","unstructured":"Russo E, Citraro R, Scicchitano F, Urzino A, Marra R, Rispoli V, de Sarro G (2011) Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav Brain Res 225:373\u2013376. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2011.07.030","journal-title":"Behav Brain Res"},{"key":"1712_CR36","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1111\/bph.13121","volume":"172","author":"R Citraro","year":"2015","unstructured":"Citraro R, Leo A, De Fazio P et al (2015) Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG\/Rij rat model of absence epilepsy. Br J Pharmacol 172:3177\u20133188. \nhttps:\/\/doi.org\/10.1111\/bph.13121","journal-title":"Br J Pharmacol"},{"key":"1712_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1528-1167.2009.02260.x","volume":"51","author":"KY Sarkisova","year":"2010","unstructured":"Sarkisova KY, Kuznetsova GD, Kulikov MA, Van Luijtelaar G (2010) Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms. Epilepsia 51:146\u2013160. \nhttps:\/\/doi.org\/10.1111\/j.1528-1167.2009.02260.x","journal-title":"Epilepsia"},{"key":"1712_CR38","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1528-1167.2011.03112.x","volume":"52","author":"E Russo","year":"2011","unstructured":"Russo E, Citraro R, Scicchitano F, de Fazio S, Perrota I, di Paola ED, Constanti A, de Sarro G (2011) Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia 52:1341\u20131350. \nhttps:\/\/doi.org\/10.1111\/j.1528-1167.2011.03112.x","journal-title":"Epilepsia"},{"key":"1712_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.neuropharm.2012.06.039","volume":"64","author":"E Russo","year":"2013","unstructured":"Russo E, Citraro R, Davoli A, Gallelli L, Donato di Paola E, de Sarro G (2013) Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology 64:371\u2013379. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.039","journal-title":"Neuropharmacology"},{"key":"1712_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neuroscience.2015.04.033","volume":"298","author":"M Jafarian","year":"2015","unstructured":"Jafarian M, Karimzadeh F, Alipour F, Attari F, Lotfinia AA, Speckmann EJ, Zarrindast MR, Gorji A (2015) Cognitive impairments and neuronal injury in different brain regions of a genetic rat model of absence epilepsy. Neuroscience 298:161\u2013170. \nhttps:\/\/doi.org\/10.1016\/j.neuroscience.2015.04.033","journal-title":"Neuroscience"},{"key":"1712_CR41","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1158\/1535-7163.MCT-15-0985-T","volume":"15","author":"N Amodio","year":"2016","unstructured":"Amodio N, Stamato MA, Gull\u00e0 AM, Morelli E, Romeo E, Raimondi L, Pitari MR, Ferrandino I et al (2016) Therapeutic targeting of miR-29b\/HDAC4 epigenetic loop in multiple myeloma. Mol Cancer Ther 15:1364\u20131375. \nhttps:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0985-T","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"1712_CR42","doi-asserted-by":"publisher","first-page":"e12477","DOI":"10.1111\/gbb.12477","volume":"17","author":"K. Y. Sarkisova","year":"2018","unstructured":"Sarkisova KY, Gabova AV (2018) Maternal care exerts disease-modifying effects on genetic absence epilepsy and comorbid depression. Genes Brain Behav 17. \nhttps:\/\/doi.org\/10.1111\/gbb.12477","journal-title":"Genes, Brain and Behavior"},{"key":"1712_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.brainres.2010.12.067","volume":"1377","author":"E Sitnikova","year":"2011","unstructured":"Sitnikova E (2011) Neonatal sensory deprivation promotes development of absence seizures in adult rats with genetic predisposition to epilepsy. Brain Res 1377:109\u2013118. \nhttps:\/\/doi.org\/10.1016\/j.brainres.2010.12.067","journal-title":"Brain Res"},{"key":"1712_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1073858417705840","volume":"24","author":"RM Hauser","year":"2018","unstructured":"Hauser RM, Henshall DC, Lubin FD (2018) The epigenetics of epilepsy and its progression. Neuroscientist 24:186\u2013200. \nhttps:\/\/doi.org\/10.1177\/1073858417705840","journal-title":"Neuroscientist"},{"key":"1712_CR45","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.2174\/1381612823666171024130001","volume":"23","author":"R Citraro","year":"2018","unstructured":"Citraro R, Leo A, Santoro M, D\u2019agostino G, Constanti A, Russo E (2018) Role of histone deacetylases (HDACs) in epilepsy and epileptogenesis. Curr Pharm Des 23:5546\u20135562. \nhttps:\/\/doi.org\/10.2174\/1381612823666171024130001","journal-title":"Curr Pharm Des"},{"key":"1712_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neuropharm.2006.05.021","volume":"51","author":"C Brandt","year":"2006","unstructured":"Brandt C, Gastens AM, Sun M z et al (2006) Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 51:789\u2013804. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2006.05.021","journal-title":"Neuropharmacology"},{"key":"1712_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1528-1157.44.s10.2.x","volume":"44","author":"LS Benardo","year":"2003","unstructured":"Benardo LS (2003) Prevention of epilepsy after head trauma: do we need new drugs or a new approach? Epilepsia 44:27\u201333. \nhttps:\/\/doi.org\/10.1046\/j.1528-1157.44.s10.2.x","journal-title":"Epilepsia"},{"key":"1712_CR48","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW et al (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice. J Neurosci 23:9418\u20139427 23\/28\/9418","journal-title":"J Neurosci"},{"key":"1712_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12640-009-9013-5","volume":"15","author":"S Eleuteri","year":"2009","unstructured":"Eleuteri S, Monti B, Brignani S, Contestabile A (2009) Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity. Neurotox Res 15:127\u2013132. \nhttps:\/\/doi.org\/10.1007\/s12640-009-9013-5","journal-title":"Neurotox Res"},{"key":"1712_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","volume":"65","author":"M Fukuchi","year":"2009","unstructured":"Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D, Takasaki I, Tabuchi A, Tsuda M (2009) Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci Res 65:35\u201343. \nhttps:\/\/doi.org\/10.1016\/j.neures.2009.05.002","journal-title":"Neurosci Res"},{"key":"1712_CR51","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.bbadis.2017.02.003","volume":"1863","author":"BL Clossen","year":"2017","unstructured":"Clossen BL, Reddy DS (2017) Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy. Biochim Biophys Acta Mol basis Dis 1863:1519\u20131538. \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2017.02.003","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"1712_CR52","doi-asserted-by":"crossref","unstructured":"Pirozzi C, Lama A, Annunziata C, Cavaliere G, De Caro C, Citraro R, Russo E, Tallarico M, Iannone M, Mollica MP, Mattace Raso G, De Sarro G, Calignano A, Meli R (2019) Butyrate prevents valproate-induced liver injury: in vitro and in vivo evidence. FASEB J In Press","DOI":"10.1096\/fj.201900927RR"},{"key":"1712_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eplepsyres.2013.06.004","volume":"106","author":"R Citraro","year":"2013","unstructured":"Citraro R, Russo E, Ngomba RT, Nicoletti F, Scicchitano F, Whalley BJ, Calignano A, de Sarro G (2013) CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. Epilepsy Res 106:74\u201382. \nhttps:\/\/doi.org\/10.1016\/j.eplepsyres.2013.06.004","journal-title":"Epilepsy Res"},{"key":"1712_CR54","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.neuropharm.2006.06.014","volume":"51","author":"R Citraro","year":"2006","unstructured":"Citraro R, Russo E, Gratteri S, di Paola ED, Ibbadu GF, Curinga C, Gitto R, Chimirri A et al (2006) Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG\/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology 51:1058\u20131067. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2006.06.014","journal-title":"Neuropharmacology"},{"key":"1712_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/epi.12118","volume":"54","author":"G Dezsi","year":"2013","unstructured":"Dezsi G, Ozturk E, Stanic D, Powell KL, Blumenfeld H, O\u2019Brien TJ, Jones NC (2013) Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy. Epilepsia 54:635\u2013643. \nhttps:\/\/doi.org\/10.1111\/epi.12118","journal-title":"Epilepsia"},{"key":"1712_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1744-9081-8-51","volume":"8","author":"A Karson","year":"2012","unstructured":"Karson A, Utkan T, Balci F et al (2012) Age-dependent decline in learning and memory performances of WAG\/Rij rat model of absence epilepsy. Behav Brain Funct 8:51. \nhttps:\/\/doi.org\/10.1186\/1744-9081-8-51","journal-title":"Behav Brain Funct"},{"issue":"8","key":"1712_CR57","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/ijms17081279","volume":"17","author":"Kathleen Saavedra","year":"2016","unstructured":"Saavedra K, Molina-M\u00e1rquez AM, Saavedra N, Zambrano T, Salazar L (2016) Epigenetic modifications of major depressive disorder. Int J Mol Sci 17. \nhttps:\/\/doi.org\/10.3390\/ijms17081279","journal-title":"International Journal of Molecular Sciences"},{"key":"1712_CR58","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.pharep.2017.08.001","volume":"70","author":"P Misztak","year":"2018","unstructured":"Misztak P, Pa\u0144czyszyn-Trzewik P, Sowa-Ku\u0107ma M (2018) Histone deacetylases (HDACs) as therapeutic target for depressive disorders. Pharmacol Rep 70:398\u2013408. \nhttps:\/\/doi.org\/10.1016\/j.pharep.2017.08.001","journal-title":"Pharmacol Rep"},{"key":"1712_CR59","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/npp.2013.128","volume":"38","author":"RJ Liu","year":"2013","unstructured":"Liu RJ, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK (2013) GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology 38:2268\u20132277. \nhttps:\/\/doi.org\/10.1038\/npp.2013.128","journal-title":"Neuropsychopharmacology"},{"key":"1712_CR60","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1126\/science.1083968","volume":"301","author":"A Caspi","year":"2003","unstructured":"Caspi A, Sugden K, Moffitt TE et al (2003) Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science (80-) 301:386\u2013389. \nhttps:\/\/doi.org\/10.1126\/science.1083968","journal-title":"Science (80-)"},{"key":"1712_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","volume":"62","author":"FA Schroeder","year":"2007","unstructured":"Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007) Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62:55\u201364. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2006.06.036","journal-title":"Biol Psychiatry"},{"key":"1712_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuropharm.2009.04.008","volume":"57","author":"BB Gundersen","year":"2009","unstructured":"Gundersen BB, Blendy JA (2009) Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 57:67\u201374. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2009.04.008","journal-title":"Neuropharmacology"},{"key":"1712_CR63","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1523\/JNEUROSCI.1758-09.2009","volume":"29","author":"HE Covington","year":"2009","unstructured":"Covington HE, Maze I, LaPlant QC et al (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29:11451\u201311460. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.1758-09.2009","journal-title":"J Neurosci"},{"key":"1712_CR64","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuropharm.2014.02.017","volume":"81","author":"A Han","year":"2014","unstructured":"Han A, Bin SY, Chung SY, Kwon MS (2014) Possible additional antidepressant-like mechanism of sodium butyrate: Targeting the hippocampus. Neuropharmacology 81:292\u2013302. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2014.02.017","journal-title":"Neuropharmacology"},{"key":"1712_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2017.12.004","volume":"1680","author":"Y Yamawaki","year":"2018","unstructured":"Yamawaki Y, Yoshioka N, Nozaki K, Ito H, Oda K, Harada K, Shirawachi S, Asano S et al (2018) Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice. Brain Res 1680:13\u201338. \nhttps:\/\/doi.org\/10.1016\/j.brainres.2017.12.004","journal-title":"Brain Res"},{"key":"1712_CR66","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2016.03.003","volume":"618","author":"J Sun","year":"2016","unstructured":"Sun J, Wang F, Hong G, Pang M, Xu H, Li H, Tian F, Fang R et al (2016) Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress. Neurosci Lett 618:159\u2013166. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2016.03.003","journal-title":"Neurosci Lett"},{"key":"1712_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052698","volume":"8","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Xing B, Dang YH, Qu CL, Zhu F, Yan CX (2013) Microinjection of valproic acid into the ventrolateral orbital cortex enhances stress-related memory formation. PLoS One 8:e52698. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0052698","journal-title":"PLoS One"},{"key":"1712_CR68","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/1535370213513987","volume":"239","author":"D Liu","year":"2014","unstructured":"Liu D, Qiu HM, Fei HZ, Hu XY, Xia HJ, Wang LJ, Qin LJ, Jiang XH et al (2014) Histone acetylation and expression of mono-aminergic transmitters synthetases involved in CUS-induced depressive rats. Exp Biol Med 239:330\u2013336. \nhttps:\/\/doi.org\/10.1177\/1535370213513987","journal-title":"Exp Biol Med"},{"key":"1712_CR69","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.tips.2010.09.003","volume":"31","author":"A Fischer","year":"2010","unstructured":"Fischer A, Sananbenesi F, Mungenast A, Tsai LH (2010) Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci 31:605\u2013617. \nhttps:\/\/doi.org\/10.1016\/j.tips.2010.09.003","journal-title":"Trends Pharmacol Sci"},{"key":"1712_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/epi.12028","volume":"54","author":"TA Glauser","year":"2013","unstructured":"Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Adamson PC et al (2013) Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 54:141\u2013155. \nhttps:\/\/doi.org\/10.1111\/epi.12028","journal-title":"Epilepsia"},{"key":"1712_CR71","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15844\/pedneurbriefs-24-3-3","volume":"24","author":"JG Millichap","year":"2015","unstructured":"Millichap JG (2015) Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. Pediatr Neurol Briefs 24:19. \nhttps:\/\/doi.org\/10.15844\/pedneurbriefs-24-3-3","journal-title":"Pediatr Neurol Briefs"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01712-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T23:55:02Z","timestamp":1596066902000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01712-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1712"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01712-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocols and the procedures reported here were approved (authorization no. 509\/2017-PR) by the Animal Care Committee of the University of Catanzaro, Italy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}